Replies to post #2811 on GW Pharmaceuticals Plc ADS (GWPH)

[lesgetrich]

They're simply saying that any added benefit of Sativex is not worth the added cost. This is a good thing for consumers and taxpayers, not so good for shareholders. Sounds to me like GW/Bayer need to cut the price to be competetive.